E.g., 04/20/2018
E.g., 04/20/2018

bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical

04 April, 2018

bioMérieux, a world leader in the field of in vitro diagnostics, announces today the acquisition of Astute Medical Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers.

Lord Jim O’Neill joins bioMérieux in a knowledge exchange on the challenge of antimicrobial resistance

07 March, 2018

Marcy l'Etoile, France, March 7, 2017 - bioMérieux, a world leader in infectious disease diagnostics, committed to the fight against antimicrobial resistance (AMR), organized today a panel discussion with Lord Jim O’Neill, an influential economist, politician and philanthropist who chaired the Review on Antimicrobial Resistance.

bioMérieux - 2017 Financial Results

28 February, 2018

February 28, 2016 – The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on February 27 under the chairmanship of Alexandre Mérieux and approved the audited consolidated financial statements for the year ended December 31, 2017.

bioMérieux – Fourth-Quarter 2017 Business Review

23 January, 2018

Marcy l'Étoile, January 23, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the twelve months ended December 31, 2017.

Inclement Weather Shipping Alert – January 2018 

16 January, 2018

Due to the impact of severe winter weather across the country, delivery services by national carriers may be interrupted.

Alexandre Mérieux appointed Chairman and CEO of bioMérieux

15 December, 2017

The Board of Directors of bioMérieux approved the appointment of Alexandre Mérieux as Chairman and CEO of the Company, taking effect immediately.

2017 End-of-Year Shipping Schedule

10 November, 2017

Please be advised that bioMérieux Inc. sites in Durham, St. Louis, Louisville and Lombard will be closed as indicated below in observance of the upcoming holidays. We encourage you to place your orders with these dates in mind to ensure you receive products as needed:

bioMérieux – Third-Quarter 2017 Business Review

19 October, 2017

Marcy l'Étoile (France), October 19, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended September 30, 2017.

bioMérieux – First-Half 2017 Results

30 August, 2017

The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on August 29 under the chairmanship of Jean-Luc Belingard and approved the consolidated financial statements for the six months ended June 30, 2017. The statements had been reviewed by the Statutory Auditors.

bioMérieux Inc. receives SERVICE 800 award 

24 August, 2017

The SERVICE 800 award recognizes client service organizations who have consistently scored at or above industry standards and benchmarks, who have demonstrated continual commitment to improving their customers’ experiences, and who have contributed input and/or support of industry association benchmark efforts.

Pioneering Diagnostics